Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
22 studies found for:    Open Studies | "Liver Cirrhosis, Biliary"
Show Display Options
Rank Status Study
1 Recruiting Phase 3 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cirrhosis
Condition: Liver Cirrhosis, Biliary
Interventions: Drug: Obeticholic Acid (OCA);   Drug: Placebo
2 Recruiting Genetic Epidemiology of Primary Biliary Cirrhosis (PBC)
Condition: Primary Biliary Cirrhosis
Intervention: Genetic: Genetic Analysis
3 Recruiting Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-responders
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Bezafibrate;   Drug: Ursodeoxycholic Acid;   Drug: Placebo (for Bezafibrate)
4 Recruiting The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland
Condition: Primary Biliary Cirrhosis
Intervention:
5 Recruiting Interrogating Potential Therapeutic Targets for Primary Biliary Cirrhosis (PBC)
Condition: Primary Biliary Cirrhosis
Interventions: Other: Clinic visit;   Other: Baseline visit
6 Recruiting Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Dietary Supplement: S-adenosyl-L-methionine
7 Recruiting Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Fenofibrate;   Drug: UDCA
8 Recruiting A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of LJN452 in PBC Patients
Condition: Primary Biliary Cirrhosis
Interventions: Drug: LJN452;   Drug: Placebo
9 Recruiting Fuzhenghuayu in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Fuzhenghuayu;   Drug: UDCA
10 Recruiting Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Fenofibrate;   Drug: UDCA
11 Recruiting Pilot Study of FFP104 Dose Escalation in PBC Subjects
Condition: Primary Biliary Cirrhosis
Intervention: Drug: FFP104
12 Recruiting Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCA
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Fenofibrate;   Drug: UDCA
13 Recruiting Fuzhenghuayu for Patients With PBC Who Had An Inadequate Response to Ursodeoxycholic Acid
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Fuzhenghuayu;   Drug: UDCA
14 Not yet recruiting MBX-8025 in Subjects With Primary Biliary Cholangitis (PBC) (8 Week, Dose Ranging, Open Label, Randomized Phase 2 With an Extension)
Condition: Primary Biliary Cirrhosis
Interventions: Drug: MBX-8025 5 mg Capsule;   Drug: MBX-8025 10 mg Capsule;   Drug: MBX-8025 25 mg Capsule
15 Recruiting Nalfurafine Hydrochloride for Pruritus in Patients With Primary Biliary Cholangitis
Condition: Primary Biliary Cirrhosis
Intervention:
16 Recruiting A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
Condition: Biliary Cirrhosis, Primary
Intervention:
17 Recruiting sCD163 in PBC Patients - Assessment of Disease Severity and Prognosis
Conditions: Primary Biliary Cirrhosis;   Liver Inflammation
Intervention: Other: Blood samples, fibroscan and questionaires
18 Recruiting sCD163 in PBC Patients - Assessment of Treatment Response
Conditions: Primary Biliary Cirrhosis;   Liver Inflammation;   Ursodeoxycholic Acid
Interventions: Other: Blood samples;   Device: Fibroscan;   Other: Questionnaires;   Biological: Liver biopsy
19 Not yet recruiting Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome
Conditions: Hepatitis, Autoimmune;   Cholangitis;   Liver Cirrhosis, Biliary;   Cholestasis
Interventions: Drug: Ursodeoxycholic acid combination of immunosuppressive agents;   Drug: Ursodeoxycholic Acid
20 Recruiting Evaluation of Patients With Liver Disease
Conditions: Biliary Liver Cirrhosis;   Hemochromatosis;   Hepatitis;   Hepatolenticular Degeneration;   Liver Disease
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-22) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.